Avid Bioservices Inc (CDMO)

[Fire Fox]

Thanks C.J. for posting SK's answer to that important Board-seat question.

My translation of King's answer is that overhauling and re-inventing the Company is a 4 step process:

(1) First, you need outstanding clinical data.

(2) Second, if you have outstanding clinical data you can attract an outstanding, world-class clinical and mfg. team like Drs. Garnick, Chabner, Garovoy and Truc Le.

(3) Third, when you have the likes of Drs. Garnick, Chabner, Garovoy and Truc Le, you can attract outstanding institutional investors.

(4) Finally, when you have had complete success in (1), (2) and (3), you are in a position to attract a truly outstanding Board of Directors.

If you try to do (4) before (2) and (3), which is what some posters on this Board seem to want, the post-split value of the pps may go to $100, but it won't go to $200 or $300.

Now in some companies the clinical data and the clinical advisors are not as outstanding as they are at PPHM. Very few biotechs can boast the likes of a Dr. Garnick or a Dr. Chabner on their team. So at those companies you may need a stronger Board before you can attract the likes of Goldman Sachs. But if the clinical data is half as good as it seems to be, and we will know that by the end of ASCO, the big funds won't wait for new Board members before they take a position.

Patience my friends. Rome wasn't built in a day. :)